HMG Stimulation vs HRT for Embryo Transfer in Women With Severe Uterine Scarring
A completed trial compares two endometrial prep strategies for IVF patients with moderate-to-severe intrauterine adhesions, a notoriously difficult fertility challenge.
Summary
Intrauterine adhesions (IUA), or scar tissue inside the uterus, are a leading cause of infertility and failed embryo transfers. Preparing the uterine lining adequately before a blastocyst transfer is especially difficult in women with moderate-to-severe IUA. This completed clinical trial from CITIC-Xiangya Hospital in China directly compared two endometrial preparation methods: stimulation with human menopausal gonadotrophin (HMG), which triggers the ovaries to produce natural hormones, versus standard hormone replacement therapy (HRT), which uses exogenous estrogen and progesterone. The goal was to determine which approach better supports uterine lining growth and improves implantation outcomes in this high-risk group. Results from this trial could meaningfully shift clinical protocols for one of reproductive medicine's most challenging patient populations.
Detailed Summary
Intrauterine adhesions, commonly caused by uterine surgery or infection, create bands of scar tissue that impair endometrial growth and dramatically reduce the chances of successful embryo implantation. Women with moderate-to-severe IUA represent one of the hardest-to-treat populations in reproductive medicine, and optimizing the uterine environment before frozen embryo transfer is critical to improving live birth rates.
This completed Phase NA clinical trial, sponsored by the Reproductive and Genetic Hospital of CITIC-Xiangya in China, set out to directly compare two endometrial preparation protocols in IUA patients undergoing blastocyst transfer. The first arm used human menopausal gonadotrophin (HMG) stimulation, which recruits natural follicular activity to generate endogenous estrogen. The second arm used conventional hormone replacement therapy (HRT), administering exogenous estradiol and progesterone to build the uterine lining artificially.
The rationale for testing HMG is that endogenous hormonal stimulation may produce a more physiologically appropriate uterine environment, potentially improving blood flow, endometrial receptivity markers, and ultimately implantation rates. HRT, while widely used, relies entirely on exogenous hormone dosing and may not fully replicate the hormonal milieu needed for optimal endometrial development in scarred tissue.
While the full results are not available in the public abstract, the completion of this trial provides an important dataset for clinicians managing IUA patients. If HMG stimulation proves superior, it could shift standard of care toward a more physiological approach in this population.
Key caveats include the limited availability of results in the abstract, the specialized patient population limiting generalizability, and the single-center design originating from one Chinese reproductive hospital. Full publication of results will be needed before clinical adoption of any protocol changes.
Key Findings
- Trial directly compared HMG ovarian stimulation versus HRT for endometrial prep in IUA patients undergoing blastocyst transfer.
- Moderate-to-severe IUA significantly impairs uterine lining development, making standard HRT protocols less reliable.
- HMG stimulation generates endogenous estrogen, potentially creating a more physiologically optimal uterine environment.
- Study is completed, suggesting results are forthcoming and could reshape frozen embryo transfer protocols for IUA patients.
- Findings may offer clinicians a new evidence-based option for one of reproductive medicine's most treatment-resistant conditions.
Methodology
This is a completed interventional clinical trial with a two-arm design comparing HMG stimulation versus HRT for endometrial preparation prior to frozen blastocyst transfer. The trial was conducted at the Reproductive and Genetic Hospital of CITIC-Xiangya, China, and enrolled women diagnosed with moderate-to-severe intrauterine adhesions. Full details on sample size, randomization, and primary endpoints are not available from the abstract alone.
Study Limitations
This summary is based on the abstract and ClinicalTrials.gov registration only, as the full study data are not publicly available. The single-center design and specialized patient population may limit generalizability to broader IVF settings. Without access to outcomes data, no conclusions can be drawn about which endometrial preparation method is superior.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.